Caption Management, LLC Agenus Inc Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $1.01 Million - $1.63 Million	500,000 New	500,000 $1.2 Million
Q3 2019 Nov 14, 2019	SELL	$2.17 - $3.14 $5,425 - $7,850	-2,500 Reduced 10.0%	22,500 $59,000
Q2 2019 Aug 13, 2019	SELL	$2.53 - $3.04 $101,452 - $121,904	-40,100 Reduced 61.6%	25,000 $75,000
Q1 2019 May 14, 2019	BUY	$2.51 - $3.73 $113,200 - $168,223	45,100 Added 225.5%	65,100 $193,000
Q4 2018 Jan 30, 2019	BUY	$1.59 - $2.66 $31,800 - $53,200	20,000 New	20,000 $48,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.